patients raffat noted patients not complete benefit called confusing note investors following conversation note raffat skeptical given positive result raffat wrote not inconceivable fda open filing fda approval translate commercial success different debate wrote investors researchers spend months struggling results meantime biogen drug available patients previously enrolled clinical trials stat delivers fast deep tough minded journalism inside science labs hospitals biotech boardrooms political backrooms dissect crucial discoveries examine controversies puncture hype hold individuals institutions accountable introduce power brokers personalities driving revolution human health stories matter march 22 2019 adam feuerstein stat february 15 2017 march 28 2019 simon makin april